was read the article
array:23 [ "pii" => "S0300289617302193" "issn" => "03002896" "doi" => "10.1016/j.arbres.2017.06.010" "estado" => "S300" "fechaPublicacion" => "2017-11-01" "aid" => "1664" "copyrightAnyo" => "2017" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "err" "cita" => "Arch Bronconeumol. 2017;53:657-8" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 2227 "formatos" => array:3 [ "EPUB" => 135 "HTML" => 1466 "PDF" => 626 ] ] "Traduccion" => array:1 [ "en" => array:18 [ "pii" => "S1579212917302008" "issn" => "15792129" "doi" => "10.1016/j.arbr.2017.06.002" "estado" => "S300" "fechaPublicacion" => "2017-11-01" "aid" => "1664" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "err" "cita" => "Arch Bronconeumol. 2017;53:657-8" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 1325 "formatos" => array:3 [ "EPUB" => 144 "HTML" => 759 "PDF" => 422 ] ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Erratum</span>" "titulo" => "Erratum to “Guidelines for the medical treatment of idiopathic pulmonary fibrosis” <[Arch. Bronconeumol. 53 (2017) 263–269]>" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "657" "paginaFinal" => "658" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Fe de errores de «Normativa sobre el tratamiento farmacológico de la fibrosis pulmonar idiopática» <[Arch Bronconeumol. 53 (2017) 263-9]>" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1466 "Ancho" => 2500 "Tamanyo" => 231768 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">IPF pharmacological treatment algorithm. FVC: forced vital capacity; DL<span class="elsevierStyleInf">CO</span>: carbon monoxide diffusing capacity.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Antoni Xaubet, María Molina-Molina, Orlando Acosta, Elena Bollo, Diego Castillo, Estrella Fernández-Fabrellas, José Antonio Rodríguez-Portal, Claudia Valenzuela, Julio Ancochea" "autores" => array:9 [ 0 => array:2 [ "nombre" => "Antoni" "apellidos" => "Xaubet" ] 1 => array:2 [ "nombre" => "María" "apellidos" => "Molina-Molina" ] 2 => array:2 [ "nombre" => "Orlando" "apellidos" => "Acosta" ] 3 => array:2 [ "nombre" => "Elena" "apellidos" => "Bollo" ] 4 => array:2 [ "nombre" => "Diego" "apellidos" => "Castillo" ] 5 => array:2 [ "nombre" => "Estrella" "apellidos" => "Fernández-Fabrellas" ] 6 => array:2 [ "nombre" => "José Antonio" "apellidos" => "Rodríguez-Portal" ] 7 => array:2 [ "nombre" => "Claudia" "apellidos" => "Valenzuela" ] 8 => array:2 [ "nombre" => "Julio" "apellidos" => "Ancochea" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0300289617302193" "doi" => "10.1016/j.arbres.2017.06.010" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289617302193?idApp=UINPBA00003Z" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212917302008?idApp=UINPBA00003Z" "url" => "/15792129/0000005300000011/v2_201711201359/S1579212917302008/v2_201711201359/en/main.assets" ] ] "itemAnterior" => array:19 [ "pii" => "S0300289617302909" "issn" => "03002896" "doi" => "10.1016/j.arbres.2017.09.001" "estado" => "S300" "fechaPublicacion" => "2017-11-01" "aid" => "1708" "copyright" => "SEPAR" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Arch Bronconeumol. 2017;53:655-6" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 2160 "formatos" => array:3 [ "EPUB" => 133 "HTML" => 1535 "PDF" => 492 ] ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Carta al Director</span>" "titulo" => "Biopsia con aguja gruesa versus punción aspiración con aguja fina en el diagnóstico del cáncer de pulmón" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "655" "paginaFinal" => "656" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Core Needle Biopsy Versus Fine Needle Aspiration Biopsy in Diagnosing Lung Cancer" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Felipe Villar Álvarez, Ignacio Muguruza Trueba, Javier Flandes Aldeyturriaga" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Felipe" "apellidos" => "Villar Álvarez" ] 1 => array:2 [ "nombre" => "Ignacio" "apellidos" => "Muguruza Trueba" ] 2 => array:2 [ "nombre" => "Javier" "apellidos" => "Flandes Aldeyturriaga" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S1579212917303142" "doi" => "10.1016/j.arbr.2017.09.009" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212917303142?idApp=UINPBA00003Z" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289617302909?idApp=UINPBA00003Z" "url" => "/03002896/0000005300000011/v1_201710310034/S0300289617302909/v1_201710310034/es/main.assets" ] "asociados" => array:1 [ 0 => array:19 [ "pii" => "S0300289617300212" "issn" => "03002896" "doi" => "10.1016/j.arbres.2016.12.011" "estado" => "S300" "fechaPublicacion" => "2017-05-01" "aid" => "1544" "copyright" => "SEPAR" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "Arch Bronconeumol. 2017;53:263-9" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 24892 "formatos" => array:3 [ "EPUB" => 205 "HTML" => 21141 "PDF" => 3546 ] ] "es" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">SEPAR habla</span>" "titulo" => "Normativa sobre el tratamiento farmacológico de la fibrosis pulmonar idiopática" "tienePdf" => "es" "tieneTextoCompleto" => "es" "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "263" "paginaFinal" => "269" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Guidelines for the medical treatment of idiopathic pulmonary fibrosis" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1759 "Ancho" => 3007 "Tamanyo" => 300771 ] ] "descripcion" => array:1 [ "es" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Algoritmo del tratamiento farmacológico de la fibrosis pulmonar idiopática.</p> <p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">CVF: capacidad vital forzada; DLco: capacidad de transferencia del monóxido de carbono.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Antoni Xaubet, María Molina-Molina, Orlando Acosta, Elena Bollo, Diego Castillo, Estrella Fernández-Fabrellas, José Antonio Rodríguez-Portal, Claudia Valenzuela, Julio Ancochea" "autores" => array:9 [ 0 => array:2 [ "nombre" => "Antoni" "apellidos" => "Xaubet" ] 1 => array:2 [ "nombre" => "María" "apellidos" => "Molina-Molina" ] 2 => array:2 [ "nombre" => "Orlando" "apellidos" => "Acosta" ] 3 => array:2 [ "nombre" => "Elena" "apellidos" => "Bollo" ] 4 => array:2 [ "nombre" => "Diego" "apellidos" => "Castillo" ] 5 => array:2 [ "nombre" => "Estrella" "apellidos" => "Fernández-Fabrellas" ] 6 => array:2 [ "nombre" => "José Antonio" "apellidos" => "Rodríguez-Portal" ] 7 => array:2 [ "nombre" => "Claudia" "apellidos" => "Valenzuela" ] 8 => array:2 [ "nombre" => "Julio" "apellidos" => "Ancochea" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S1579212917300782" "doi" => "10.1016/j.arbr.2017.03.001" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212917300782?idApp=UINPBA00003Z" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289617300212?idApp=UINPBA00003Z" "url" => "/03002896/0000005300000005/v1_201704280943/S0300289617300212/v1_201704280943/es/main.assets" ] ] "es" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Fe de errores</span>" "titulo" => "Fe de errores de «Normativa sobre el tratamiento farmacológico de la fibrosis pulmonar idiopática» <[Arch Bronconeumol. 53 (2017) 263-9] >" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "657" "paginaFinal" => "658" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Antoni Xaubet, María Molina-Molina, Orlando Acosta, Elena Bollo, Diego Castillo, Estrella Fernández-Fabrellas, José Antonio Rodríguez-Portal, Claudia Valenzuela, Julio Ancochea" "autores" => array:9 [ 0 => array:4 [ "nombre" => "Antoni" "apellidos" => "Xaubet" "email" => array:1 [ 0 => "axaubetmir@gmail.com" ] "referencia" => array:3 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] 2 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "María" "apellidos" => "Molina-Molina" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] ] ] 2 => array:3 [ "nombre" => "Orlando" "apellidos" => "Acosta" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">d</span>" "identificador" => "aff0020" ] ] ] 3 => array:3 [ "nombre" => "Elena" "apellidos" => "Bollo" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">e</span>" "identificador" => "aff0025" ] ] ] 4 => array:3 [ "nombre" => "Diego" "apellidos" => "Castillo" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">f</span>" "identificador" => "aff0030" ] ] ] 5 => array:3 [ "nombre" => "Estrella" "apellidos" => "Fernández-Fabrellas" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">g</span>" "identificador" => "aff0035" ] ] ] 6 => array:3 [ "nombre" => "José Antonio" "apellidos" => "Rodríguez-Portal" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">h</span>" "identificador" => "aff0040" ] ] ] 7 => array:3 [ "nombre" => "Claudia" "apellidos" => "Valenzuela" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">i</span>" "identificador" => "aff0045" ] ] ] 8 => array:3 [ "nombre" => "Julio" "apellidos" => "Ancochea" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">i</span>" "identificador" => "aff0045" ] ] ] ] "afiliaciones" => array:9 [ 0 => array:3 [ "entidad" => "Servicio de Neumología, Hospital Clínic, Barcelona, España" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), España" "etiqueta" => "b" "identificador" => "aff0010" ] 2 => array:3 [ "entidad" => "Unidad Funcional del Intersticio Pulmonar (UFIP), Servicio de Neumología, Hospital Universitario de Bellvitge-Instituto de Investigación Biomédica de Bellvitge (IDIBELL), L’Hospitalet de Llobregat, Barcelona, España" "etiqueta" => "c" "identificador" => "aff0015" ] 3 => array:3 [ "entidad" => "Servicio de Neumología, Hospital Universitario de Canarias, Santa Cruz de Tenerife, España" "etiqueta" => "d" "identificador" => "aff0020" ] 4 => array:3 [ "entidad" => "Servicio de Neumología, Complejo Asistencial Universitario de León, León, España" "etiqueta" => "e" "identificador" => "aff0025" ] 5 => array:3 [ "entidad" => "Servicio de Neumología, Hospital de la Santa Creu i Sant Pau, Barcelona, España" "etiqueta" => "f" "identificador" => "aff0030" ] 6 => array:3 [ "entidad" => "Servicio de Neumología, Consorcio Hospital General Universitario de Valencia, Valencia, España" "etiqueta" => "g" "identificador" => "aff0035" ] 7 => array:3 [ "entidad" => "Servicio de Neumología, Hospital Universitario Virgen del Rocío, Sevilla, España" "etiqueta" => "h" "identificador" => "aff0040" ] 8 => array:3 [ "entidad" => "Servicio de Neumología, Hospital Universitario de La Princesa, Universidad Autónoma de Madrid, Madrid, España" "etiqueta" => "i" "identificador" => "aff0045" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Autor para correspondencia." ] ] ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Erratum to “Guidelines for the medical treatment of idiopathic pulmonary fibrosis” <[Arch Bronconeumol. 53 (2017) 263–9] >" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1465 "Ancho" => 2500 "Tamanyo" => 234504 ] ] "descripcion" => array:1 [ "es" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Algoritmo del tratamiento farmacológico de la fibrosis pulmonar idiopática.</p> <p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">CVF: capacidad vital forzada; Dlco: capacidad de transferencia del monóxido de carbono.</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">En el artículo “Normativa sobre el tratamiento farmacológico de la fibrosis pulmonar idiopática” publicado en Arch Bronconeumol. 2017;53:263-9, se han detectado varios errores en las <a class="elsevierStyleCrossRefs" href="#tbl0005">tablas 1 y 5</a>, en la <a class="elsevierStyleCrossRef" href="#fig0005">figura 1</a> y en el texto.</p><p id="par0010" class="elsevierStylePara elsevierViewall">Las tablas correctas son las siguientes:</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><elsevierMultimedia ident="tbl0010"></elsevierMultimedia><p id="par0015" class="elsevierStylePara elsevierViewall">La <a class="elsevierStyleCrossRef" href="#fig0005">figura 1</a> correcta es la siguiente:</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0020" class="elsevierStylePara elsevierViewall">El texto correcto es el siguiente:<ul class="elsevierStyleList" id="lis0005"><li class="elsevierStyleListItem" id="lsti0005"><span class="elsevierStyleLabel">-</span><p id="par0025" class="elsevierStylePara elsevierViewall">Página 3, apartado “Nintedanib (Ofev®)”, línea 57. Donde dice: “En los estudios INPULSIS, los pacientes con riesgo cardiovascular fueronexcluidos y, por tanto, no se conoce con certeza la seguridad (tabla 3). En la tabla 4 se especifican las interacciones medicamentosas denintedanib.”, debe decir: “En la tabla 4 se especifican las interacciones medicamentosas denintedanib.”</p></li><li class="elsevierStyleListItem" id="lsti0010"><span class="elsevierStyleLabel">-</span><p id="par0030" class="elsevierStylePara elsevierViewall">Página 5, apartado “Fármacos antifibróticos en fase de ensayo clínico”, línea 31. Donde dice “Entre estas combinaciones están: pirfenidona<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>lebrikizumab (estudio RIFF), pirfenidona o ninteda-nib<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>PRM-151 (estudio PROMEDIOR), pirfenidona<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>vismodegib (estudio GB29764), pirfenidona<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>sildenafilo”, debe decir: “Entre estas combinaciones están:pirfenidona<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>lebrikizumab (estudio RIFF), pirfenidona o ninteda-nib<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>PRM-151 (estudio PROMEDIOR), pirfenidona<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>vismodegib(estudio GB29764), pirfenidona<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>sildenafilo, nintedabid+/- sildefanilo (estudio INSTAGE y otros estudios en marcha NCT02606877 (nintedanib<span class="elsevierStyleHsp" style=""></span>+<span class="elsevierStyleHsp" style=""></span>pirfenidona o el estudio INMARK.”</p></li><li class="elsevierStyleListItem" id="lsti0015"><span class="elsevierStyleLabel">-</span><p id="par0035" class="elsevierStylePara elsevierViewall">Página 5, el título del apartado “Enfisema pulmonar” debe sustituirse por: “Síndrome combinado de fibrosis pulmonar con enfisema (CPFE)”.</p></li><li class="elsevierStyleListItem" id="lsti0020"><span class="elsevierStyleLabel">-</span><p id="par0040" class="elsevierStylePara elsevierViewall">Página 5, apartado “Enfisema pulmonar”, línea 1. Donde dice: “En la actualidad, no existen tratamientos eficaces para el síndrome CPFE (coexistencia de enfisema y FPI)<span class="elsevierStyleSup">35,36</span>, de tal manera que parece lógico tomar decisiones terapéuticas basadas en las recomendaciones por separado para el enfisema y la FPI.”, debe decir: “En la actualidad, no existen tratamientos eficaces para el síndrome CPFE<span class="elsevierStyleSup">35,36</span>, de tal manera que parece lógico tomar decisiones terapéuticas basadas en las recomendaciones por separado para el enfisema y la FPI.”</p></li></ul></p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "multimedia" => array:3 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1465 "Ancho" => 2500 "Tamanyo" => 234504 ] ] "descripcion" => array:1 [ "es" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Algoritmo del tratamiento farmacológico de la fibrosis pulmonar idiopática.</p> <p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">CVF: capacidad vital forzada; Dlco: capacidad de transferencia del monóxido de carbono.</p>" ] ] 1 => array:8 [ "identificador" => "tbl0005" "etiqueta" => "Tabla 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at1" "detalle" => "Tabla " "rol" => "short" ] ] "tabla" => array:2 [ "leyenda" => "<p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">DLCO: capacidad de transferencia del monóxido de carbono; FVC: capacidad vital forzada; NIU neumonía intersticial usual; TCAR: tomografía axial computarizada de alta resolución.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="" valign="top" scope="col" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">CAPACITY-1 y 2<br>(n= 779) \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">ASCEND<br>(n= 555) \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Edad (años) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">40-80 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">40-80 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">FVC (criterio inclusión) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">≥ 50-90% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">50-90% \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">DLCO (criterio inclusión) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">≥ 35-90% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">≥ 30-90% \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Fase \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top"><span class="elsevierStyleSmallCaps">III</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top"><span class="elsevierStyleSmallCaps">III</span> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Tiempo estudio (semanas) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">72 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">52 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">TCAR NIU \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">92% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">95,7% \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">FVC al inicio (media) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">74,1% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">67,8% \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">DLCO al inicio (media) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">47% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">43,7% \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1578157.png" ] ] ] ] "descripcion" => array:1 [ "es" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Características metodológicas y clínicas de los pacientes con fibrosis pulmonar idiopática incluidos en los ensayos clínicos CAPACITY-1 y 2, y ASCEND</p>" ] ] 2 => array:8 [ "identificador" => "tbl0010" "etiqueta" => "Tabla 5" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at2" "detalle" => "Tabla " "rol" => "short" ] ] "tabla" => array:2 [ "leyenda" => "<p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">DLCO: capacidad de transferencia del monóxido de carbono; FVC: capacidad vital forzada; NIU neumonía intersticial usual; TCAR: tomografía axial computarizada de alta resolución.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="" valign="top" scope="col" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">TOMORROW<br>(n<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>422, 85 a dosis 150<span class="elsevierStyleHsp" style=""></span>mg/12<span class="elsevierStyleHsp" style=""></span>h) \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">INPULSIS-1 y 2<br>(n<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>1.066) \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Edad (años) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">>40 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">>40 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">FVC (criterio inclusión) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">≥50% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">≥50% \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">DLCO (criterio inclusión) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">30-79% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">30-79% \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Fase \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top"><span class="elsevierStyleSmallCaps">II</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top"><span class="elsevierStyleSmallCaps">III</span> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Tiempo estudio (semanas) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">52 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">52 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">TCAR NIU \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">38,8% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">76% \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">FVC al inicio (media) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">78,1% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">79,5% \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">DLCO al inicio (media) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">– \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">47% \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1578156.png" ] ] ] ] "descripcion" => array:1 [ "es" => "<p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Características metodológicas y clínicas de los pacientes con fibrosis pulmonar idiopática incluidos en los ensayos clínicos TOMORROW e INPULSIS</p>" ] ] ] ] "idiomaDefecto" => "es" "url" => "/03002896/0000005300000011/v1_201710310034/S0300289617302193/v1_201710310034/es/main.assets" "Apartado" => array:4 [ "identificador" => "66993" "tipo" => "SECCION" "es" => array:2 [ "titulo" => "Fe de errores" "idiomaDefecto" => true ] "idiomaDefecto" => "es" ] "PDF" => "https://static.elsevier.es/multimedia/03002896/0000005300000011/v1_201710310034/S0300289617302193/v1_201710310034/es/main.pdf?idApp=UINPBA00003Z&text.app=https://archbronconeumol.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289617302193?idApp=UINPBA00003Z" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 3 | 2 | 5 |
2024 October | 49 | 14 | 63 |
2024 September | 56 | 12 | 68 |
2024 August | 70 | 30 | 100 |
2024 July | 40 | 23 | 63 |
2024 June | 81 | 19 | 100 |
2024 May | 72 | 22 | 94 |
2024 April | 57 | 25 | 82 |
2024 March | 53 | 27 | 80 |
2024 February | 42 | 26 | 68 |
2023 December | 1 | 0 | 1 |
2023 August | 4 | 2 | 6 |
2023 June | 1 | 0 | 1 |
2023 April | 2 | 2 | 4 |
2023 March | 23 | 7 | 30 |
2023 February | 83 | 32 | 115 |
2023 January | 46 | 25 | 71 |
2022 December | 103 | 37 | 140 |
2022 November | 105 | 31 | 136 |
2022 October | 90 | 45 | 135 |
2022 September | 106 | 33 | 139 |
2022 August | 123 | 54 | 177 |
2022 July | 108 | 47 | 155 |
2022 June | 117 | 33 | 150 |
2022 May | 124 | 57 | 181 |
2022 April | 106 | 35 | 141 |
2022 March | 108 | 57 | 165 |
2022 February | 113 | 39 | 152 |
2022 January | 106 | 38 | 144 |
2021 December | 61 | 48 | 109 |
2021 November | 108 | 49 | 157 |
2021 October | 80 | 46 | 126 |
2021 September | 45 | 50 | 95 |
2021 August | 52 | 42 | 94 |
2021 July | 44 | 38 | 82 |
2021 June | 48 | 54 | 102 |
2021 May | 63 | 52 | 115 |
2021 April | 94 | 131 | 225 |
2021 March | 82 | 40 | 122 |
2021 February | 75 | 43 | 118 |
2021 January | 51 | 25 | 76 |
2020 December | 61 | 36 | 97 |
2020 November | 55 | 31 | 86 |
2020 October | 60 | 29 | 89 |
2020 September | 53 | 20 | 73 |
2020 August | 44 | 24 | 68 |
2020 July | 62 | 38 | 100 |
2020 June | 41 | 22 | 63 |
2020 May | 60 | 23 | 83 |
2020 April | 52 | 25 | 77 |
2020 March | 51 | 35 | 86 |
2020 February | 52 | 38 | 90 |
2020 January | 48 | 44 | 92 |
2019 December | 65 | 24 | 89 |
2019 November | 39 | 24 | 63 |
2019 October | 40 | 20 | 60 |
2019 September | 41 | 16 | 57 |
2019 August | 45 | 17 | 62 |
2019 July | 47 | 28 | 75 |
2019 June | 46 | 20 | 66 |
2019 May | 54 | 27 | 81 |
2019 April | 60 | 40 | 100 |
2019 March | 60 | 32 | 92 |
2019 February | 42 | 31 | 73 |
2019 January | 46 | 20 | 66 |
2018 December | 48 | 24 | 72 |
2018 November | 110 | 44 | 154 |
2018 October | 163 | 39 | 202 |
2018 September | 63 | 20 | 83 |
2018 July | 3 | 0 | 3 |
2018 June | 1 | 0 | 1 |
2018 May | 63 | 5 | 68 |
2018 April | 88 | 19 | 107 |
2018 March | 108 | 33 | 141 |
2018 February | 107 | 29 | 136 |
2018 January | 9 | 2 | 11 |
2017 December | 5 | 1 | 6 |
2017 November | 35 | 22 | 57 |
2017 October | 1 | 12 | 13 |
2017 September | 0 | 14 | 14 |